Merck Donates $500,000 to Support River Blindness and Lymphatic Filariasis Elimination Efforts

▴ Merck Donates $500,000 to Support River Blindness and Lymphatic Filariasis Elimination Efforts
Merck and the MECTIZAN Donation Program, announced today a $500,000 cash donation to support NGO partners working to eliminate onchocerciasis and lymphatic filariasis

Merck, known as MSD outside the United States and Canada, and the MECTIZAN Donation Program (MDP), announced today a $500,000 cash donation to support non-governmental organization (NGO) partners working to eliminate river blindness (onchocerciasis) and lymphatic filariasis (LF). The funds are being provided by Merck and will be administered through an application process managed by the MDP, a public-private partnership that oversees elimination efforts of these two diseases. This funding will be offered in the form of grants to support the implementation of the World Health Organization’s (WHO’s) recommended precautionary measures to decrease the risk of the spread of SARS-CoV-2 during mass drug administration (MDA).

In April, in response to the pandemic, WHO issued interim guidance to countries to suspend community interventions targeting the elimination of neglected tropical diseases, including MDA. After months of careful assessment, in July, WHO released a decision-making framework for resuming MDA during the ongoing pandemic. The framework is based on a two-step approach: a risk–benefit assessment to decide if the planned activity should proceed; and, if activities move forward, a list of precautionary measures that should be applied to help decrease the risk of transmission of SARS-CoV-2 and strengthen the capacity of the health system to manage any residual risk. These important precautionary measures will result in an increase in program costs, which may be a burden to some countries and their implementing partners.

“The SARS-CoV-2 pandemic is especially challenging for communities that continue to be threatened by river blindness and lymphatic filariasis. We can’t lose momentum and must strengthen our global partnerships to eliminate these infections,” said Dr. Julie L. Gerberding, chief patient officer at Merck. “We hope these grants will help sustain the implementation of good public health measures and protect people’s safety as they fight against these preventable diseases during this especially difficult time.”

Dr. Yao Sodahlon, MDP Director, stated "As the global community continues to battle the SARS-CoV-2 pandemic, we remain committed to the health of our staff, the health of our partners, and the health of endemic communities. This grant opportunity will facilitate the implementation of robust safety measures when mass drug administration with MECTIZAN resumes.”

Through the MDP and its partners -- including the ministries of health in endemic countries, impacted communities, NGOs, WHO, and donors -- more than 300 million people are reached each year. Since the inception of the program in 1987, Merck has donated more than 4 billion treatments.

Tags : #LatestPhramaNewsOct22 #LatestMerckNewsOct22 #Onchocerciasis #RiverBlindness #LymphaticFilariasis

About the Author


Sana Farid Khan

“The best way to become acquainted with a subject is to write about it."
A confident counselor, a speaker, and an educator, ready to utilize my communication skills effectively in the world of healthcare by putting pen to paper to reach new heights of success.
You can write to me at [email protected]

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Actor-Director Sathish Kaushik Died of a Heart Attack at the Age of 66March 09, 2023
Soleus Push-Ups: A Laziest Exercise to Lower Blood Sugar LevelsMarch 09, 2023
World Kidney Day 2023: Be Aware of Kidney DiseasesMarch 09, 2023
Sushmita Sen reveals about suffering from a severe heart attack recently and Addison's disease in 2014March 06, 2023
A significant increase in influenza A H3N2 patients that are accompanied by severe coughing and feverMarch 06, 2023
Is AIDS or HIV curable in Ayurveda?March 03, 2023
Artificial Sweetener Erythritol Raises the Possibility of Heart Attack.March 01, 2023
Difference between HIV and AIDS - When to give antiretroviral therapy?March 01, 2023
Zero Discrimination Day: Let's Raise the Voice Against DiscriminationMarch 01, 2023
International Women’s Day 2023 – Embrace EquityFebruary 28, 2023
Brain Tumors - Types, Symptoms and Risk FactorsFebruary 28, 2023
World Rare Disease Day: End Stigma Against Rare Diseases.February 28, 2023
National Science Day 2023 - Global Science for Global WellbeingFebruary 28, 2023
Eating disorders - Types and their complicationsFebruary 27, 2023
The condition that took away the life of Malayalam filmmaker, Joseph ManuFebruary 27, 2023
World NGO Day 2023 - We make a living by what we get, but we make a life by what we giveFebruary 27, 2023
Functions and Problems of SerotoninFebruary 25, 2023
Arthritis management – Tips to manage arthritis effectivelyFebruary 25, 2023
Apple has undertaken a project of no-prick blood sugar monitoring feature for its watch.February 24, 2023
Bird flu – Jharkhand on alert, know its prevention and symptoms in humansFebruary 24, 2023